迪卡斯 DCTH 深 滬
已收盤 12-12 16:00:00 美东时间
10.37
-0.020
-0.19%
華盛通- 最 高10.65
- 今 開10.605
- 成交量 77.24万股
- 最 低 10.3001
- 昨 收 10.39
- 總市值 3.63亿
- 52周最高 18.23
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 8.12
- 委 比 96.48%
- 總股本 3498.13万
- 歷史最高 9368800000.00
- 量 比 1.30
- 振 幅 3.37%
- 歷史最低 2.25
- 每 手 1
- 風險率 2.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Delcath Systems 10-Year Data From Retrospective Study On Patients With Liver-Dominant Metastatic Uveal Melanoma Shows Safety, Efficacy Of CHEMOSAT
Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of a retrospective
12-04 05:06
Delcath Systems Announces $25M Buyback Plan
Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath") an interventional oncology company focused on the treatment of primary and metastatic cancers to the liver, today announced that its Board of Directors has authorized a
11-21 05:02
Delcath Systems Announces Retrospective Study From The University Of Tubingen, Analyzing Long-Term Survivors With Liver Metastases From Uveal Melanoma
Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of results from a
11-13 21:39
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
Delcath Systems shares are trading lower after the company reported mixed Q3 financial results.
Delcath Systems shares are trading lower after the company reported mixed Q3 fi...
11-05 01:24
BTIG Reiterates Buy on Delcath Systems, Maintains $23 Price Target
BTIG analyst Marie Thibault reiterates Delcath Systems (NASDAQ:DCTH) with a Buy and maintains $23 price target.
11-05 01:10
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
美股大行评级 | 富国银行上调苹果目标价升至290美元；"卖出"！花旗下调NuScale Power、阿特斯太阳能评级
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从30美元升至44美元；Piper Sandler：维持Vital Energy"中性"评级，目标价从16美元升至30美元
10-22 10:10
Canaccord Genuity Maintains Buy on Delcath Systems, Maintains $21 Price Target
Canaccord Genuity analyst John Newman maintains Delcath Systems (NASDAQ:DCTH) with a Buy and maintains $21 price target.
10-22 00:29
